Importance Infarction patterns may serve as important imaging markers to assess the
probability of stroke recurrence in transient ischemic attack (TIA) and minor stroke. However …

Objective Many patients receiving dual antiplatelet therapy still had recurrent strokes. We
aimed to identify factors associated with recurrent stroke at 90 days in patients receiving …

Importance Dual antiplatelet therapy with clopidogrel and aspirin is effective for secondary
prevention after minor ischemic stroke or transient ischemic attack (TIA). Uncertainties …

Background: Randomized controlled trials (RCTs) proved that short-term (21–90 days) dual
antiplatelet therapy (DAPT) reduces the risk of early ischemic recurrences after a …

Objective: We aimed to investigate whether the efficacy and safety of clopidogrel plus aspirin
vs aspirin alone were consistent between patients with and without intracranial arterial …

Importance Results show the short-term risk of hemorrhage in treating patients with acute
transient ischemic attack (TIA) or minor acute ischemic stroke (AIS) with clopidogrel plus …

Background: In patients with acute minor ischemic stroke or high-risk transient ischemic
attack enrolled in the POINT trial (Platelet-Oriented Inhibition in New TIA and Minor Ischemic …

Background Dual antiplatelet treatment has been shown to lower the risk of recurrent stroke
as compared with aspirin alone when treatment is initiated early (≤ 24 hours) after an acute …

Objective: To investigate the short-term time course risks and benefits of clopidogrel with
aspirin in minor ischemic stroke or TIA. Methods: Data were derived from the Clopidogrel in …

Background Combination antiplatelet therapy with clopidogrel and aspirin may reduce the
rate of recurrent stroke during the first 3 months after a minor ischemic stroke or transient …